×

Please Remove Adblock
Adverts are the main source of Revenue for DoveMed. Please remove adblock to help us create the best medical content found on the Internet.

CDC Update: Connecticut Anthrax Case and Today's Telebriefing Transcript and Audio Clip

Last updated March 15, 2020

Approved by: Subramanian Malaisamy MD, MRCP (UK), FCCP (USA)

Connecticut Inhalation Anthrax Case Confirmed


CDC Update: Connecticut Anthrax Case and Today's Telebriefing Transcript and Audio Clip

Connecticut Inhalation Anthrax Case Confirmed

CDC has confirmed a case of inhalational anthrax in Connecticut. CDC was contacted by the Connecticut Department of Public Health about a respiratory illness in a 94-year-old female which preliminary tests had indicated to be anthrax. CDC conducted PCR (polymerase chain reaction) testing on specimens from the woman and confirmed anthrax. In addition to confirming the anthrax case, CDC initially sent an assessment team (5 persons) to Connecticut to assist state health department officials. Today, an additional 12 persons from CDC – including environmental health specialists, epidemiologists, EIS officers, and others – will be joining the team in Connecticut.

Summary of Local, State, and Federal Confirmed Human Cases and Exposures

Case Status Florida NYC NJ D.C. CT Total

Confirmed 2 5 5 5 1 18

    Cutaneous 0 4 3 0 0  

    Inhalational 2 1 2 5 1  

Suspect 0 3 2 0   5

    Cutaneous 0 3 2 0    

    Inhalational 0 0 0 0    

There have been 5 deaths associated with inhalational anthrax.

CDC confirmed cases are based on a rigorous case definition, which was published in CDC’s Morbidity and Mortality Weekly Report (MMWR) on October 19, 2001. The MMWR is available on-line at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5041a1.htm.

CDC defines a confirmed case of anthrax as 1) a clinically compatible case of cutaneous, inhalational, or gastrointestinal illness that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or 2) other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests. CDC defines a suspect case as 1) a clinically compatible case of illness without isolation of B. anthracis and no alternative diagnosis, but with laboratory evidence of B. anthracis by one supportive laboratory test or 2) a clinically compatible case of anthrax epidemiologically linked to a confirmed environmental exposure, but without corroborative laboratory evidence of B. anthracis infection.

Today’s telebriefing transcript and audio clip

The transcript from today’s telebriefing (Minnesota knee surgery deaths) with Drs. Julie Gerberding and Dan Jernigan is available online. Today's briefing was also webcast and the audio clip is also available online. Both transcript and audio clip are accessible from www.cdc.gov/media/transcripts.htm.

For the latest update on CDC activities and on-going anthrax investigations visit www.bt.cdc.gov or www.cdc.gov/media.

 

References and Information Sources used for the Article:


Materials:


Reviewed and Approved by a member of the DoveMed Editorial Board
First uploaded: March 15, 2020
Last updated: March 15, 2020